Energy Based Therapeutics Market Overview:
The Energy Based Therapeutics Market Size was estimated at 29.36 (USD Billion) in 2022. The Energy Based Therapeutics Market Industry is expected to grow from 32.72 (USD Billion) in 2023 to 86.7 (USD Billion) by 2032. The Energy Based Therapeutics Market CAGR (growth rate) is expected to be around 11.43% during the forecast period (2024 - 2032).
Key Energy Based Therapeutics Market Trends Highlighted
The market for energy-based therapeutics is expected to witness considerable growth due to technological progress, the growing prevalence of acute diseases and an increase in non-invasive treatment options.
The importance of artificial intelligence (AI) and machine learning (ML) is great, and their introduction changes everything because tissues are targeted for treatment. Furthermore, the increasing attention on preventive treatment and understanding of the usefulness of energy based treatments are giving more chances to the players in the market. Novel technologies such as high-intensity focused ultrasound (HIFU) and transcranial magnetic stimulation (TMS) are being adopted, and this is associated with a cure for many conditions.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Energy Based Therapeutics Market Drivers
Rising Prevalence of Chronic Diseases
The Energy Based Therapeutics Market Industry is expected to witness significant growth over the forecast period, owing to the increasing prevalence of chronic diseases, rising healthcare expenditure, and growing awareness of energy-based therapies. The market is expected to be driven by the rising demand for non-invasive and cost-effective treatment options for chronic diseases. Energy-based therapies offer a range of benefits, including reduced pain and inflammation and improved tissue healing and immune function.
As a result, they are increasingly being used in the treatment of a wide range of conditions, including cancer, cardiovascular diseases, and neurological disorders. The rising prevalence of chronic diseases is one of the key factors driving the demand for energy-based therapeutics. Chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, are often long-term and expensive to treat. Energy-based therapies provide a non-invasive, cost-effective, and often more effective alternative to traditional treatments.
For example, they can help reduce pain, inflammation, and other symptoms associated with chronic diseases, thereby improving the quality of life for patients. As a result, the demand for energy-based therapies is expected to grow as the prevalence of chronic diseases continues to rise. The growing awareness of the benefits of energy-based therapies is another key factor contributing to their increasing popularity. Patients and healthcare providers are becoming increasingly aware of the benefits of energy-based therapies, such as reduced pain and inflammation, improved tissue healing, and enhanced immune function.
As a result, these therapies are increasingly being used to treat a wide range of conditions, including cancer, cardiovascular diseases, and neurological disorders. Overall, the Energy Based Therapeutics Market Industry is expected to grow significantly over the coming years, driven by the increasing prevalence of chronic diseases, rising healthcare expenditure, and growing awareness of energy-based therapies.
Technological Advancements
Advancements in technology are leading to the development of new and more effective energy-based therapeutic devices. These devices are becoming more portable, affordable, and user-friendly, which is making them more accessible to patients. Additionally, the development of new energy sources, such as lasers and radiofrequency, is expanding the range of applications for energy-based therapies. As technology continues to advance, the Energy Based Therapeutics Market Industry is expected to benefit from the development of new and more effective treatment options.
Growing Adoption of Integrative Medicine
The growing adoption of integrative medicine is also contributing to the growth of the Energy Based Therapeutics Market Industry. Integrative medicine combines conventional medicine with complementary and alternative medicine practices, such as energy-based therapies. As more healthcare providers adopt integrative medicine approaches, the demand for energy-based therapies is expected to increase.
Energy Based Therapeutics Market Segment Insights:
Energy Based Therapeutics Market Device Type Insights
The Energy Based Therapeutics Market is segmented by Device Type into Radiofrequency Ablation Devices, Cryoablation Devices, Laser Devices, Focused Ultrasound Devices, and Microwave Ablation Devices. Among these, in 2023, Radiofrequency Ablation Devices held the largest market share.
The Energy Based Therapeutics Market for Radiofrequency Ablation Devices is expected to increase from USD 9.12 Billion in 2023 to USD 22.43 Billion by 2032, at a CAGR of 11.2%. The growth of this segment is due to the increasing prevalence of cancer, the increasing adoption of minimally invasive procedures, and the advancement of technology of radiofrequency ablation devices. While Cryoablation Devices are expected to increase most rapidly over the assessment period, this is because these devices can be used to target and eliminate tumors precisely without affecting surrounding normal tissues.
The Energy Based Therapeutics Market for Laser Devices is expected to reach USD 15.34 Billion by 2032, growing at an estimated CAGR of 10.9%. Laser Devices allow more control compared to other energy-based devices, therefore increasing accuracy, having a lower level of invasiveness, and a lower level of the likelihood of complications.
Meanwhile, Focused Ultrasound Devices are becoming increasingly popular due to their non-invasiveness and ability to be applied in a range of conditions, including tumors and non-tumors: uterine fibroids and prostate. Microwave Ablation Devices are also expected to perform steadily throughout the forecast period as there is an increasing demand for minimally invasive treatment for liver cancer and hepatitis. In conclusion, the Device Type segment of the Energy Based Therapeutics Market is expected to grow heavily over the discussion due to the increasing prevalence of chronic diseases and the increasing popularity of minimally invasive procedures.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Energy Based Therapeutics Market Technological Advancements Insights
Technologies are transforming the Global Energy Based Therapeutics Market, boosting market expansion and offering new avenues for development. Robotized Surgery appears as a trend in this field, as it allows performing less invasive medical surgeries with high precision. Particularly, Artificial Intelligence and Machine Learning make diagnostics and therapeutic intervention planning more efficient, thus enhancing treatment outcomes. In addition, 3D Imaging uncovers the details of anatomy, which makes therapy performance more accurate. Moreover, technologies expand access to treatment options, which is especially critical for the application of energy-based therapies.
For example, telemedicine allows patients to receive medical help without physical presence, which is suitable for therapy applications in remote areas. According to the source, these technologies will constitute the greatest share of revenue in the Global Energy Based Therapeutics Market. The total market revenue is projected to be equal to USD 37.23 bn in 2024.
Energy Based Therapeutics Market Therapeutic Application Insights
The Therapeutic Application segment of the Energy Based Therapeutics Market is poised for significant growth, driven by the increasing prevalence of chronic diseases such as cancer, cardiovascular disease, and pain. Cancer Treatment held the largest market share of 36.8% in 2023 and is projected to continue its dominance throughout the forecast period. The rising incidence of cancer worldwide and the effectiveness of energy-based therapies in treating various types of cancer are key factors contributing to this growth. Cardiovascular Disease Treatment is another major segment, with a market share of 28.4% in 2023.
The increasing prevalence of cardiovascular diseases, coupled with the growing adoption of energy-based therapies for heart rhythm disorders and coronary artery disease, is driving the growth of this segment. Pain Management is also a significant segment, with a market share of 22.1% in 2023. The rising incidence of chronic pain conditions and the efficacy of energy-based therapies in alleviating pain are fueling the growth of this segment. Neurostimulation and Aesthetic Treatments are other important segments, with market shares of 8.9% and 3.8%, respectively, in 2023.
Neurostimulation is gaining traction for treating neurological disorders such as epilepsy and Parkinson's disease, while Aesthetic Treatments are becoming increasingly popular for non-invasive cosmetic procedures. Overall, the Therapeutic Application segment of the Energy Based Therapeutics Market is expected to witness substantial growth in the coming years, driven by the rising demand for effective and minimally invasive treatments for various therapeutic applications.
Energy Based Therapeutics Market Target Anatomy Insights
Target Anatomy, The global energy-based therapeutics market for liver, lung, kidney, heart, and spine, is estimated to be valued at USD 10.2 billion in 2023 and is projected to reach USD 27.4 billion by 2032, growing at a CAGR of 12.3% during the forecast period. The growth of the market is attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive procedures, and technological advancements in energy-based devices. Liver: The liver is one of the most common target anatomies for energy-based therapeutics, with a wide range of applications, including tumor ablation, hemostasis, and tissue welding.
The rising incidence of liver cancer and the need for effective and minimally invasive treatment options are driving the growth of the market. Lung: Energy-based therapeutics are increasingly used in the treatment of lung diseases, such as lung cancer and chronic obstructive pulmonary disease (COPD). The ability of these devices to access hard-to-reach areas of the lung and deliver targeted therapy is fueling the growth of the lung target anatomy segment.
Kidney: The use of energy-based therapeutics in the treatment of kidney diseases, such as kidney stones and kidney tumors, is growing rapidly. These devices offer a less invasive and more effective alternative to traditional surgical procedures, driving the growth of the kidney target anatomy segment.
Heart: Energy-based therapeutics are used in various cardiac procedures, including ablation of arrhythmias, treatment of heart failure, and valvular repair. The growing prevalence of cardiovascular diseases and the need for improved treatment outcomes are contributing to the expansion of the heart target anatomy segment.
Spine: Energy-based therapeutics are used in the treatment of a variety of spinal disorders, such as spinal stenosis, herniated discs, and tumors. The minimally invasive nature of these devices and their ability to provide targeted therapy are boosting the growth of the spine target anatomy segment.
Energy Based Therapeutics Market Procedure Type Insights
The procedure Type segment plays a critical role in the Global Energy Based Therapeutics Market, influencing market growth and investment strategies. Open Surgery, Minimally Invasive Surgery, Non-Invasive Surgery, Radiation Therapy, and Chemotherapy are the key procedure types within this segment. In 2024, Minimally Invasive Surgery held a dominant market share of 38.7%, owing to its advantages of reduced tissue damage and faster recovery time.
Non-Invasive Surgery is projected to exhibit the highest growth rate of 13.2% during the forecast period (2023-2032), driven by the increasing adoption of advanced technologies and growing patient preference for less invasive procedures. Radiation Therapy and Chemotherapy are expected to maintain steady growth rates of 9.4% and 8.6%, respectively, contributing to the overall market expansion.
Energy Based Therapeutics Market Regional Insights
The Energy Based Therapeutics Market segmentation by region showcases prominent regional markets, including North America, Europe, APAC, South America, and MEA. North America accounts for a significant share of the market due to the presence of advanced healthcare infrastructure, high disposable income, and increasing awareness about energy-based therapies. Europe follows closely, driven by government initiatives to promote innovative healthcare technologies and a large patient population.
APAC is expected to witness substantial growth in the coming years, owing to rising healthcare expenditure, increasing prevalence of chronic diseases, and growing adoption of energy-based therapies in emerging economies like China and India.South America and MEA represent emerging markets with untapped potential, offering opportunities for market expansion.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Energy Based Therapeutics Market Key Players And Competitive Insights:
Major players in Energy Based Therapeutics Market industry are continuously focusing on the development of new and innovative products to gain a competitive edge in the market. Leading Energy Based Therapeutics Market players are also actively involved in strategic partnerships, mergers, and acquisitions to expand their global footprint and strengthen their market position.
The Energy Based Therapeutics Market is highly competitive, with a number of major players vying for market share. Some of the leading players in the market include Alma Lasers, BTL Industries, Cynosure, Fotona, Lumenis, and Syneron Candela. These companies offer a wide range of energy-based devices for various applications, including skin tightening, hair removal, tattoo removal, and body contouring.
The Energy Based Therapeutics Market is expected to grow at a significant rate in the coming years, driven by increasing demand for non-invasive and effective aesthetic treatments.Alma Lasers is a leading global provider of energy-based aesthetic and medical solutions. The company offers a wide range of products, including lasers, IPL systems, and radiofrequency devices. Alma Lasers has a strong presence in over 80 countries and is known for its innovative technology and clinical expertise.
The company is committed to providing safe and effective treatments for a variety of skin conditions and aesthetic concerns.Lumenis is another major player in the Energy Based Therapeutics Market. The company offers a comprehensive range of energy-based devices for aesthetic, medical, and surgical applications. Lumenis has a strong focus on research and development and is constantly innovating new technologies to meet the needs of its customers. The company has a global presence and is committed to providing high-quality products and services to its customers.
Key Companies in the Energy Based Therapeutics Market Include:
- BTL
- Femi Lift
- 3D Technologies
- Norav Medical
- Zimmer Biomet
- Ellman International
- HT Medical
- Unique Health
- Capenergy
- Chattanooga Group
- Erbe Elektromedizin
- Orthofix Medical
- Theracane
- DJO
- RS Medical
Energy Based Therapeutics Market Industry Developments
The energy-based therapeutics market is projected to grow significantly over the next decade, driven by the rising prevalence of chronic diseases, increasing demand for minimally invasive procedures, and technological advancements. In 2023, the market was valued at USD 32.72 billion and is expected to reach USD 86.7 billion by 2032, exhibiting a CAGR of 11.43%.
Key market players are focusing on developing innovative technologies and expanding their global presence through strategic collaborations and acquisitions. Recent news developments include the FDA approval of new energy-based devices for the treatment of various conditions, such as cancer, pain management, and aesthetics.
Energy Based Therapeutics Market Segmentation Insights
- Energy Based Therapeutics Market Device Type Outlook
- Radiofrequency Ablation Devices
- Cryoablation Devices
- Laser Devices
- Focused Ultrasound Devices
- Microwave Ablation Devices
- Energy Based Therapeutics Market Technological Advancements Outlook
- Robotic Surgery
- Artificial Intelligence
- Machine Learning
- 3D Imaging
- Telemedicine
- Energy Based Therapeutics Market Therapeutic Application Outlook
- Cancer Treatment
- Cardiovascular Disease Treatment
- Pain Management
- Neurostimulation
- Aesthetic Treatments
- Energy Based Therapeutics Market Target Anatomy Outlook
- Liver
- Lung
- Kidney
- Heart
- Spine
- Energy Based Therapeutics Market Procedure Type Outlook
- Open Surgery
- Minimally Invasive Surgery
- Non-Invasive Surgery
- Radiation Therapy
- Chemotherapy
- Energy Based Therapeutics Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2022 |
29.36 (USD Billion) |
| Market Size 2023 |
32.72 (USD Billion) |
| Market Size 2032 |
86.7 (USD Billion) |
| Compound Annual Growth Rate (CAGR) |
11.43% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
BTL, Femi Lift, 3D Technologies, Norav Medical, Zimmer Biomet, Ellman International, HT Medical, Unique Health, Capenergy, Chattanooga Group, Erbe Elektromedizin, Orthofix Medical, Theracane, DJO, RS Medical |
| Segments Covered |
Device Type, Technological Advancements, Therapeutic Application, Target Anatomy, Procedure Type, Regional |
| Key Market Opportunities |
Increasing demand for noninvasive therapies Rising prevalence of chronic diseases Technological advancements Growing awareness of energy-based therapies Integration of energy-based therapies into traditional healthcare systems |
| Key Market Dynamics |
Rising prevalence of chronic diseases Technological advancements Growing demand for noninvasive therapies Increasing geriatric population Government initiatives |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Energy Based Therapeutics Market is expected to reach USD 86.7 billion by 2032, exhibiting a CAGR of 11.43% during the forecast period (2023-2032).
North America is expected to dominate the Global Energy Based Therapeutics Market, accounting for the largest market share during the forecast period.
The rising prevalence of chronic diseases, increasing adoption of minimally invasive procedures, and technological advancements are the key growth drivers of the Global Energy Based Therapeutics Market.
Energy Based Therapeutics find applications in various medical specialties, such as urology, gastroenterology, dermatology, and orthopedics.
Some of the key competitors in the Energy Based Therapeutics Market include Lumenis, Boston Scientific, Medtronic, and Johnson & Johnson.
The Energy Based Therapeutics Market is expected to reach USD 57.2 billion by 2028.
Asia Pacific is expected to exhibit the highest growth rate in the Energy Based Therapeutics Market during the forecast period.
Reimbursement issues, regulatory hurdles, and a lack of skilled professionals are some of the challenges faced by the Global Energy Based Therapeutics Market.
Technological advancements such as the development of new energy sources and improved delivery systems are expected to drive the growth of the Global Energy Based Therapeutics Market.
The increasing adoption of robotic surgery, personalized medicine, and remote monitoring are some of the emerging trends in the Global Energy Based Therapeutics Market.
